vs

Side-by-side financial comparison of INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) and MACROGENICS INC (MGNX). Click either name above to swap in a different company.

INNOVATIVE INDUSTRIAL PROPERTIES INC is the larger business by last-quarter revenue ($66.7M vs $41.2M, roughly 1.6× MACROGENICS INC). On growth, MACROGENICS INC posted the faster year-over-year revenue change (113.0% vs -13.1%). Over the past eight quarters, MACROGENICS INC's revenue compounded faster (112.8% CAGR vs -6.0%).

Oxford Properties is a Canadian multinational corporation, with operations in real estate investment, development and property management. Its portfolio includes office, retail, industrial, multi-residential, life sciences and hotel assets. Established privately in 1960 and later wholly owned by the Ontario Municipal Employees Retirement System (OMERS) since 2003, the company is headquartered in Toronto with regional head offices in New York City, London, Australia, Singapore and Luxembourg. ...

MacroGenics Inc is a clinical-stage biopharmaceutical firm specializing in the research and development of novel immunotherapies for cancer and autoimmune disorders. Its core product pipeline centers on monoclonal antibody-based treatments, with key programs targeting solid tumors and hematological malignancies, supported by partnerships with global pharmaceutical partners.

IIPR vs MGNX — Head-to-Head

Bigger by revenue
IIPR
IIPR
1.6× larger
IIPR
$66.7M
$41.2M
MGNX
Growing faster (revenue YoY)
MGNX
MGNX
+126.2% gap
MGNX
113.0%
-13.1%
IIPR
Faster 2-yr revenue CAGR
MGNX
MGNX
Annualised
MGNX
112.8%
-6.0%
IIPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IIPR
IIPR
MGNX
MGNX
Revenue
$66.7M
$41.2M
Net Profit
$31.8M
Gross Margin
Operating Margin
47.8%
-29.3%
Net Margin
47.8%
Revenue YoY
-13.1%
113.0%
Net Profit YoY
-20.4%
EPS (diluted)
$1.07
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IIPR
IIPR
MGNX
MGNX
Q4 25
$66.7M
$41.2M
Q3 25
$64.7M
$72.8M
Q2 25
$62.9M
$22.2M
Q1 25
$71.7M
$13.2M
Q4 24
$76.7M
$19.4M
Q3 24
$76.5M
$110.7M
Q2 24
$79.8M
$10.8M
Q1 24
$75.5M
$9.1M
Net Profit
IIPR
IIPR
MGNX
MGNX
Q4 25
$31.8M
Q3 25
$29.3M
$16.8M
Q2 25
$26.0M
$-36.3M
Q1 25
$31.1M
$-41.0M
Q4 24
$40.0M
Q3 24
$40.2M
$56.3M
Q2 24
$42.0M
$-55.7M
Q1 24
$39.4M
$-52.2M
Gross Margin
IIPR
IIPR
MGNX
MGNX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
98.8%
Q3 24
99.8%
Q2 24
98.4%
Q1 24
97.0%
Operating Margin
IIPR
IIPR
MGNX
MGNX
Q4 25
47.8%
-29.3%
Q3 25
45.5%
25.6%
Q2 25
45.9%
-165.3%
Q1 25
47.4%
-323.1%
Q4 24
54.7%
-273.0%
Q3 24
54.8%
48.9%
Q2 24
53.1%
-538.9%
Q1 24
55.7%
-590.4%
Net Margin
IIPR
IIPR
MGNX
MGNX
Q4 25
47.8%
Q3 25
45.3%
23.1%
Q2 25
41.4%
-163.0%
Q1 25
43.3%
-311.1%
Q4 24
52.2%
Q3 24
52.6%
50.9%
Q2 24
52.6%
-515.6%
Q1 24
52.3%
-573.3%
EPS (diluted)
IIPR
IIPR
MGNX
MGNX
Q4 25
$1.07
$-0.23
Q3 25
$0.97
$0.27
Q2 25
$0.86
$-0.57
Q1 25
$1.03
$-0.65
Q4 24
$1.35
$-0.24
Q3 24
$1.37
$0.90
Q2 24
$1.44
$-0.89
Q1 24
$1.36
$-0.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IIPR
IIPR
MGNX
MGNX
Cash + ST InvestmentsLiquidity on hand
$47.6M
$57.2M
Total DebtLower is stronger
$393.7M
Stockholders' EquityBook value
$1.8B
$55.6M
Total Assets
$2.4B
$256.8M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IIPR
IIPR
MGNX
MGNX
Q4 25
$47.6M
$57.2M
Q3 25
$41.9M
$80.1M
Q2 25
$104.9M
$130.7M
Q1 25
$133.3M
$145.6M
Q4 24
$151.2M
$182.8M
Q3 24
$172.4M
$179.6M
Q2 24
$160.9M
$83.9M
Q1 24
$173.5M
$80.4M
Total Debt
IIPR
IIPR
MGNX
MGNX
Q4 25
$393.7M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IIPR
IIPR
MGNX
MGNX
Q4 25
$1.8B
$55.6M
Q3 25
$1.9B
$67.0M
Q2 25
$1.9B
$46.6M
Q1 25
$1.9B
$79.1M
Q4 24
$1.9B
$116.1M
Q3 24
$1.9B
$120.1M
Q2 24
$1.9B
$57.8M
Q1 24
$2.0B
$106.2M
Total Assets
IIPR
IIPR
MGNX
MGNX
Q4 25
$2.4B
$256.8M
Q3 25
$2.3B
$270.8M
Q2 25
$2.3B
$245.4M
Q1 25
$2.4B
$224.6M
Q4 24
$2.4B
$261.7M
Q3 24
$2.4B
$264.5M
Q2 24
$2.4B
$201.1M
Q1 24
$2.4B
$248.3M
Debt / Equity
IIPR
IIPR
MGNX
MGNX
Q4 25
0.21×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IIPR
IIPR
MGNX
MGNX
Operating Cash FlowLast quarter
$198.2M
$43.0M
Free Cash FlowOCF − Capex
$42.8M
FCF MarginFCF / Revenue
103.8%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
6.22×
TTM Free Cash FlowTrailing 4 quarters
$-83.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IIPR
IIPR
MGNX
MGNX
Q4 25
$198.2M
$43.0M
Q3 25
$45.6M
$-30.2M
Q2 25
$48.4M
$-47.0M
Q1 25
$54.2M
$-46.9M
Q4 24
$258.4M
$-38.4M
Q3 24
$64.9M
$60.2M
Q2 24
$64.2M
$-44.5M
Q1 24
$71.6M
$-45.6M
Free Cash Flow
IIPR
IIPR
MGNX
MGNX
Q4 25
$42.8M
Q3 25
$-30.6M
Q2 25
$-47.7M
Q1 25
$-47.4M
Q4 24
$-39.0M
Q3 24
$59.6M
Q2 24
$-45.5M
Q1 24
$-47.1M
FCF Margin
IIPR
IIPR
MGNX
MGNX
Q4 25
103.8%
Q3 25
-42.0%
Q2 25
-214.5%
Q1 25
-359.5%
Q4 24
-201.7%
Q3 24
53.8%
Q2 24
-421.6%
Q1 24
-517.4%
Capex Intensity
IIPR
IIPR
MGNX
MGNX
Q4 25
0.6%
Q3 25
0.6%
Q2 25
3.2%
Q1 25
4.0%
Q4 24
3.2%
Q3 24
0.5%
Q2 24
9.6%
Q1 24
16.0%
Cash Conversion
IIPR
IIPR
MGNX
MGNX
Q4 25
6.22×
Q3 25
1.56×
-1.79×
Q2 25
1.86×
Q1 25
1.75×
Q4 24
6.46×
Q3 24
1.61×
1.07×
Q2 24
1.53×
Q1 24
1.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IIPR
IIPR

Segment breakdown not available.

MGNX
MGNX

Revenue From Collaborative Agreements$20.3M49%
Contract Manufacturing$11.3M27%
Other$9.7M23%

Related Comparisons